Showing results (1331-1340 of 1,431) with videos related to

Sort By:
Pageof 144
Human Mutation|October 13, 2018
Expert specification of the ACMG/AMP variant interpretation guidelines for genetic hearing lossAndrea M Oza, Marina T DiStefano, Sarah E Hemphill, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Cellular Modeling of CLN6 with IPSC-derived Neurons and GliaMaria Gabriela Otero, Jaemin Kim, Yogesh Kumar Kushwaha, et al.
JCO Precision Oncology|February 9, 2022
Minimally Invasive Real-Time Detection of Actionable Mutations in Patients With Metastatic Solid Tumors Using Fine-Needle and Liquid BiopsiesKyaw L Aung, Philippe L Bedard, Celeste Yu, et al.
Gynecologic Oncology|August 23, 2016
Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2Bradley J Monk, Andrés Poveda, Ignace Vergote, et al.
Gynecologic Oncology|June 19, 2022
Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancerRachel Campbell, Daniel S J Costa, Martin R Stockler, et al.
Gynecologic Oncology|October 23, 2022
Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinomaDavid M O'Malley, Amit M Oza, Domenica Lorusso, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 7, 2021
Phase II Trial of Symptom Screening With Targeted Early Palliative Care for Patients With Advanced CancerCamilla Zimmermann, Ashley Pope, Breffni Hannon, et al.
Therapeutic Advances in Medical Oncology|April 29, 2026
Predictors of prolonged progression-free survival in patients with unresectable or recurrent pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid (NAPOLEON-2 study)Yasunori Kawaguchi, Kohei Hayashi, Mototsugu Shimokawa, et al.
Journal of Vascular Research|April 11, 2021
Vascular Patterning as Integrative Readout of Complex Molecular and Physiological Signaling by VESsel GENeration AnalysisMark Lagatuz, Ruchi J Vyas, Marina Predovic, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 22, 2024
How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in patients with platinum sensitive recurrent ovarian cancer and long-term outcomesLucy Haggstrom, Yeh Chen Lee, Clare Scott, et al.
Pageof 144